Mary E. Holland

Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million.

Inovise Medical, Inc. develops, produces and distributes cardiology products. The firms products includes Audicor AM monitor, Audicor sensor 4.0 and Audicor TS data sheet. The company was founded in by Patricia White in March 1997 and is headquartered in Beaverton, OR.

FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA.

Great Wolf Resorts Holdings, Inc. owns and operates indoor water parks and resorts. The firm offers arcade and game rooms, fitness rooms, themed restaurants, spas, supervised children's activities, and other amenities. The company was founded in 1997 and is headquartered in Chicago, IL.

Veran Medical Technologies, Inc. designs, develops, and markets soft tissue equipment. The firm's main focus is assisting physicians in the early diagnosis and treatment of lung cancer. The company was founded by Ben Heavrin, Bruce Lynskey, Jerome R. Edwards, and Evan Austill, Jr. in 2005 and is headquartered in St. Louis, MO.

Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA.

Sonoma Orthopedic Products, Inc. develops and manufactures orthopedic devices. The company was founded by Stephen D. Guntherand and Charles L. Nelson in 2005 and is headquartered in Buffalo Grove, IL.

CSA Medical, Inc. develops endoscopic cryoablation systems. It provides spray cryotherapy medical device solutions that improve patient outcomes, simplify procedures, and reduce the cost of healthcare. The company was founded by Lloyd Shue, Timothy E. Askew and Frank Majerowicz in 1985 and is headquartered in Lexington, MA.

VIDA Diagnostics, Inc. engages in the production and sale of diagnostic software solutions. The firm?s products help for early detection, evaluation, and treatment of pulmonary diseases including COPD (emphysema, chronic bronchitis), lung cancer, and asthma. The company was founded by Eric Hoffman, Milan Sonka, Joseph Reinhardt, and Geoffrey McLennan in 2004 and is headquartered in Coralville, IA.

Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.

First Analysis Securities Corp. (FAS) is a research-driven investment organization headquartered in Chicago, Illinois and was founded in 1981. The firm is a subsidiary of First Analysis Corp. FAS serves emerging growth companies with private equity/venture capital investments, corporations with corporate finance and merger and acquisition services, and financial institutions with the public equity research and private equity limited partnerships.

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Mason Wells Inc (Private Equity)(Mason Wells) is a private equity subsidiary of Marshall & Ilsley Corporation founded in 1998 by John Thomas Byrnes. The firm is headquartered in the Milwaukee, Wisconsin.

Part of Medtronic Plc, Metracor Technologies, Inc. is a company that develops health monitoring systems. The company is based in San Diego, CA. Metracor Technologies was acquired by Infrasonics, Inc. on May 12, 1992.

Prolog Ventures LLC is a venture capital firm founded in 2000 by Brian Clevinger, Greg Johnson and Ilya Nykin. The firm is headquartered in Clayton, Missouri.

First Analysis Corp (First Analysis) is a venture capital firm founded in 1981 by Francis Oliver Nicklin. The firm is headquartered in Chicago, Illinois.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA.

Part of Sartorius AG, Stedim, Inc. is a company that manufactures single-use containment systems specifically for the biopharmaceutical market and drug-delivery applications. The company is based in Concord, CA.

Founded in 1987, BioForward is a member-driven state association and venture capital investor located in Madison, Wisconsin. The firm serves as the voice of Wisconsin's bioscience industry. They advocate on their members behalf to create investment and partnership opportunities, attract and retain the best people and support public policy that fosters their continued growth. BioForward also provides member-support services including networking opportunities through a variety of conferences and events, online resources and group purchasing programs. Their members include bioscience companies, universities, non-profit organizations, service providers, as well as state, regional and local government representatives. BioForward was previously known as the Wisconsin Biotechnology & Medical Device Association.

Phenomenelle Angels LLC (Phenomenelle Angels) is a venture capital firm founded in 2006 by Lauren A. Flanagan and Joe P. Hildebrandt. The firm is headquartered in Madison, Wisconsin.

Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd

eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

Yunu, Inc. provides medical research technology and services to life sciences companies and clinical research environments. The company is based in Pittsboro, NC. The company's aim is to ensure breakthrough therapies are accessible to everyone by unifying medical imaging insights and connecting clinical communities. Yunu is delivering a new standard for clinical trial imaging workflow with thousands of clinical trials relying on the platform daily. The company is serving life science companies and cancer centers to ignite collaboration and accelerate innovation. Yunu offers a resource center for all clinical trial imaging workflow resources in one place and connects cross-site study teams, sponsors, core labs, CROs, and off-site clinical resources through their platform called Yunuverse. The CEO of the company is Jeffrey Sorenson.

Merganser Biotech, Inc. engages in the development of of hepcidin mimetic peptides as new medicines for the treatment of hematological and iron overload diseases. The company was founded by Brian R. MacDonald and Gene Merutka in 2011 and is headquartered in Newtown Square, PA.